Folio · SPXSet Report · Digest
v0.7.0 STABLE · 2026-11-11 · r4

2026-W46 · Nov 9–Nov 15 · Company · Profile · published

Index >>> Company >>> Profile

Humana Inc. (HUM) — XLV Health Care · S&P 500 Profile |Humana公司介紹

health-careS&P500xlv
SPXSet Studio
IN-HOUSE RESEARCH · 站內獨立研究

Humana Inc. (HUM) — Business, History & S&P 500 Profile | Humana公司介紹

Humana Inc. company profile · business segments · history · financial snapshot · S&P 500 rank #232 · Humana公司業務歷史財務與標普500地位

中文版 ↓

PROFILE
Market data as of Oct 30, 2026 (ET) close
Financials: FY2025
MARKET CAP
$49.77B
Oct 30, 2026 close
S&P 500 WEIGHT
0.07%
Rank #232 · Oct 30, 2026
SECTOR RANK
#30
Health Care · Oct 30, 2026
S&P 500 RANK
#232
0.07% · Oct 30, 2026

SNAPSHOT

TickerHUM
CompanyHumana Inc.
GICS sector / industryHealth Care (XLV) / Managed Health Care
S&P 500 rank (by weight)#232 · 0.07% (Oct 30, 2026)
Sector rank#30 in Health Care (Oct 30, 2026)
HeadquartersLouisville, Kentucky
Founded1961
CEOJim Rechtin (CEO)
Employees67,060 (2025)
Market cap$49.77B (Oct 30, 2026)
Share price$414.50 (Oct 30, 2026)
SEC filingsEDGAR — CIK 0000049071

WHAT IT DOES

Humana Inc. is a for-profit health insurer based in Louisville, Kentucky, centred on government-sponsored health plans — above all Medicare Advantage for seniors. It is the second-largest Medicare Advantage parent organisation by enrollment on KFF's 2026 reporting, and the fourth-largest U.S. health insurer on the ranking cited in its company profile.

Its one-line model: collect capitated premiums from the federal government and states per member, pay their medical benefits, and keep the spread — while its CenterWell arm earns service revenue delivering the primary care, pharmacy and home-health services those members use. About 93% of revenue comes from government-sponsored programmes.

The economics are spread economics on thin margins: fiscal 2025 revenue was $129.66B, but the Insurance benefit ratio was about 90.2% and net income only $1.19B (a 0.9% net margin). Membership and Medicare Star Ratings — which set bonus payments — therefore matter more than revenue growth: total medical membership was 15.0 million at December 31, 2025.

BUSINESS SEGMENTS

Insurance — Medicare AdvantageIndividual and group Medicare Advantage plans, the core book: 5.25 million individual MA members at December 31, 2025, after plan exits and benefit redesign; the Insurance segment reported total revenue of $124.6B in fiscal 2025 including intersegment revenue.
Insurance — Medicaid & State-Based ContractsMedicaid managed care and other state-based contracts, plus military services through Humana Military (TRICARE).
Insurance — Medicare Supplement & Prescription Drug PlansStandalone Part D prescription-drug plans and Medicare Supplement cover sold alongside the MA book.
CenterWell — Primary CareCenterWell Senior Primary Care and Conviva senior-focused clinics: 350 clinics and about 491,100 patients at December 31, 2025.
CenterWell — PharmacyCenterWell Pharmacy and Specialty Pharmacy dispensing, largely to Humana's own members (intersegment).
CenterWell — Home HealthCenterWell Home Health, operating in 37 states with roughly 68% overlap with Humana's individual MA membership. The CenterWell segment reported total revenue of $22.5B in fiscal 2025, of which $17.7B was intersegment.

Insurance — Medicare Advantage Individual and group Medicare Advantage plans, the core book: 5.25 million individual MA members at December 31, 2025, after plan exits and benefit redesign; the Insurance segment reported total revenue of $124.6B in fiscal 2025 including intersegment revenue.

Insurance — Medicaid & State-Based Contracts Medicaid managed care and other state-based contracts, plus military services through Humana Military (TRICARE).

Insurance — Medicare Supplement & Prescription Drug Plans Standalone Part D prescription-drug plans and Medicare Supplement cover sold alongside the MA book.

CenterWell — Primary Care CenterWell Senior Primary Care and Conviva senior-focused clinics: 350 clinics and about 491,100 patients at December 31, 2025.

CenterWell — Pharmacy CenterWell Pharmacy and Specialty Pharmacy dispensing, largely to Humana's own members (intersegment).

CenterWell — Home Health CenterWell Home Health, operating in 37 states with roughly 68% overlap with Humana's individual MA membership. The CenterWell segment reported total revenue of $22.5B in fiscal 2025, of which $17.7B was intersegment.

HISTORY

YearMilestone
1961Lawyers David A. Jones Sr. and Wendell Cherry found a nursing-home company in Louisville on August 18, 1961 (as Extendicare Inc.); it becomes the largest U.S. nursing-home company before the founders sell the chain and buy hospitals in 1972.
1974The company is renamed Humana Inc. in 1974 and grows into one of the world's largest hospital companies in the 1980s; when a hospital loses an HMO contract, Humana creates its own health plan — the origin of the insurer.
1993Humana spins off its hospital operations as Galen Health Care in 1993 (sold the next year), completing the pivot from hospital operator to health insurer.
2017Aetna's agreed $37B acquisition of Humana (announced July 2015) is blocked on antitrust grounds and cancelled in February 2017, leaving Humana independent and Medicare-focused.
2024Jim Rechtin becomes CEO on July 1, 2024, succeeding Bruce Broussard, and begins a margin-recovery programme: exiting unprofitable counties and products, including the completed exit from employer-group commercial medical cover.

COMPETITIVE POSITION

  • Medicare Advantage scale: second-largest MA parent by enrollment (KFF, 2026), with 5.25 million individual MA members at end-2025 — a pure-play senior focus its diversified rivals do not match.
  • Vertical integration: CenterWell's 350 primary-care clinics, pharmacy and home health mainly serve Humana members, so care delivery and insurance economics sit in one P&L — CenterWell earned a fiscal 2025 operating margin of about 6.0% on $22.5B of segment revenue, several times the Insurance segment's margin.
  • Government dependence as a moat and a risk: about 93% of revenue is government-funded, giving predictable capitated revenue but total exposure to CMS rates and Star Ratings.
  • Competition set: UnitedHealthcare, Elevance Health, CVS-Aetna and Cigna in Medicare and Medicaid managed care.

FINANCIAL SNAPSHOT

Total revenue$129.66B (FY2025 revenue)
Operating income$2.70B (FY2025 operating income)
Net income$1.19B (FY2025 net income)
Diluted EPS$9.84 (FY2025 GAAP diluted EPS)
Source: Humana fiscal 2025 Form 10-K (year ended December 31, 2025) — revenue, operating and net income via Wikipedia company profile (10-K figures) corroborated by 10-K reporting; GAAP diluted EPS $9.84 per the company's results reporting (adjusted EPS was $17.14). Segment revenue is segment total including intersegment revenue; Insurance $124.6B plus CenterWell $22.5B less $17.7B intersegment eliminations reconciles to consolidated revenue. Benefit ratio about 90.2% (Insurance, fiscal 2025).

KEY RISKS

  • Star Ratings: the fall in the share of members in 4-star-plus plans (from 94% to about 20% on 10-K reporting) creates a multi-billion-dollar bonus-payment headwind for 2026 and beyond.
  • Medical cost trend: benefit ratio about 90.2% leaves almost no cushion if utilisation rises faster than premiums.
  • Government pricing: CMS Medicare Advantage rates, the v28 risk model and Medicaid redeterminations are set by the same payer that funds about 93% of revenue.
  • Membership vs margin: the margin-recovery programme shrank membership in 2025 (total medical members down to 15.0 million); regrowth in 2026 must not re-import unprofitable members.
  • Regulatory and litigation exposure typical of large Medicare contractors, including risk-adjustment audits.

WHY IT MATTERS FOR THE S&P 500

Humana is a small-weight health-care constituent: rank #232 by weight at 0.07% as of Oct 30, 2026, and #30 in Health Care. As the index's most Medicare-Advantage-pure large insurer, its benefit ratio and Star Ratings are the sector's clearest live gauge of U.S. government health-programme economics.

SOURCES & METHODOLOGY

Financials, segments, headquartersHumana fiscal 2025 Form 10-K data via Wikipedia company profile and 10-K-based reporting (year ended December 31, 2025); headquarters, CEO and employees via Wikipedia company profile
Index weight & ranksSlickcharts S&P 500 weights, Oct 30, 2026 close, fetched Nov 2, 2026 (dispatch baseline, used verbatim)
Market cap$49.77B (Oct 30, 2026)
LogoSPXSet logo library, compiled from company official websites, filings, or Wikipedia; as company logos are dynamic corporate information, no 100% guarantee is made for the graphics.
ChartSPXSet chart library, monthly bars, compiled from Yahoo public information.

Price Chart — 10-Year Monthly Candles

HUM

Source: Yahoo Finance monthly bars, split-adjusted · Data as of Sep 30, 2026 (last closed month) · SPXSet.com

FINANCIALS

繁體中文版

公司快照

股票代號HUM
公司Humana Inc.(Humana)
GICS 板塊/行業醫療保健(XLV)/管理式醫療保健
標普500排名(按權重)#232 · 0.07%(Oct 30, 2026)
板塊內排名醫療保健 #30(Oct 30, 2026)
總部美國肯塔基州路易斯維爾
成立1961年
執行長Jim Rechtin(執行長)
員工67,060(2025年)
市值$49.77B(Oct 30, 2026)
股價$414.50(Oct 30, 2026)
SEC 申報EDGAR — CIK 0000049071

業務概覽

Humana 是一家總部位於肯塔基州路易斯維爾的營利性健康保險公司,核心是政府資助的健康計劃——首推面向長者的 Medicare Advantage。按 KFF 2026 年報道,它是 Medicare Advantage 第二大母機構;按其公司資料引用的排名,它是美國第四大健康保險公司。

其一句話商業模式是:向聯邦政府與各州按會員收取定額保費,支付會員的醫療福利,並保留差額——同時其 CenterWell 部門透過提供會員所用的基層醫療、藥房與家居健康服務賺取服務收入。約 93% 的收入來自政府資助計劃。

其經濟學是利差薄的利差經濟:2025 財年收入 1,296.6 億美元,但保險福利比率約 90.2%,淨利潤僅 11.9 億美元(淨利率 0.9%)。因此會員數與決定獎金支付的 Medicare 星級評級比收入增長更重要:截至 2025 年 12 月 31 日,醫療會員總數為 1,500 萬。

業務板塊

保險 — Medicare Advantage個人與團體 Medicare Advantage 計劃,是核心業務:截至 2025 年 12 月 31 日,個人 MA 會員 525 萬(經計劃退出與福利重設之後);保險板塊 2025 財年總收入(含板塊間收入)為 1,246 億美元。
保險 — Medicaid 與州合約Medicaid 管理式醫療及其他州合約,以及透過 Humana Military(TRICARE)提供的軍方服務。
保險 — Medicare 補充與處方藥計劃獨立的 Part D 處方藥計劃與 Medicare 補充保障,與 MA 業務並行銷售。
CenterWell — 基層醫療CenterWell Senior Primary Care 與 Conviva 的長者診所:截至 2025 年 12 月 31 日共 350 家診所、約 491,100 名患者。
CenterWell — 藥房CenterWell Pharmacy 與 Specialty Pharmacy 配藥,主要服務 Humana 自家會員(板塊間)。
CenterWell — 家居健康CenterWell Home Health,在 37 個州營運,與 Humana 個人 MA 會員的重疊約 68%。CenterWell 板塊 2025 財年總收入 225 億美元,其中 177 億美元為板塊間收入。

保險 — Medicare Advantage 個人與團體 Medicare Advantage 計劃,是核心業務:截至 2025 年 12 月 31 日,個人 MA 會員 525 萬(經計劃退出與福利重設之後);保險板塊 2025 財年總收入(含板塊間收入)為 1,246 億美元。

保險 — Medicaid 與州合約 Medicaid 管理式醫療及其他州合約,以及透過 Humana Military(TRICARE)提供的軍方服務。

保險 — Medicare 補充與處方藥計劃 獨立的 Part D 處方藥計劃與 Medicare 補充保障,與 MA 業務並行銷售。

CenterWell — 基層醫療 CenterWell Senior Primary Care 與 Conviva 的長者診所:截至 2025 年 12 月 31 日共 350 家診所、約 491,100 名患者。

CenterWell — 藥房 CenterWell Pharmacy 與 Specialty Pharmacy 配藥,主要服務 Humana 自家會員(板塊間)。

CenterWell — 家居健康 CenterWell Home Health,在 37 個州營運,與 Humana 個人 MA 會員的重疊約 68%。CenterWell 板塊 2025 財年總收入 225 億美元,其中 177 億美元為板塊間收入。

歷史沿革

年份里程碑
1961律師 David A. Jones Sr. 與 Wendell Cherry 於 1961 年 8 月 18 日在路易斯維爾創立一家護老院公司(名為 Extendicare Inc.);它成為美國最大的護老院公司,創辦人其後於 1972 年出售該連鎖並買入醫院。
1974公司於 1974 年更名為 Humana Inc.,並在 1980 年代成長為全球最大的醫院公司之一;當一家醫院失去 HMO 合約後,Humana 自設健康計劃——這正是其保險業務的起源。
1993Humana 於 1993 年把醫院業務分拆為 Galen Health Care(翌年出售),完成由醫院營運商向健康保險公司的轉型。
2017Aetna 已同意的 370 億美元收購 Humana 交易(2015 年 7 月宣布)因反壟斷理由被阻止,並於 2017 年 2 月取消,Humana 保持獨立並專注 Medicare。
2024Jim Rechtin 於 2024 年 7 月 1 日接替 Bruce Broussard 出任執行長,展開利潤率復甦計劃:退出無利可圖的縣與產品,包括已完成的僱主團體商業醫療保障退出。

競爭地位

  • Medicare Advantage 規模:MA 第二大母機構(KFF,2026 年),2025 年末個人 MA 會員 525 萬——多元化對手所沒有的純長者專注。
  • 垂直整合:CenterWell 的 350 家基層醫療診所、藥房與家居健康主要服務 Humana 會員,令護理交付與保險經濟學置於同一損益表——CenterWell 2025 財年以 225 億美元板塊收入取得約 6.0% 營業利潤率,為保險板塊利潤率的數倍。
  • 政府依賴既是護城河也是風險:約 93% 收入由政府資助,帶來可預測的定額收入,但同時完全曝露於 CMS 費率與星級評級。
  • 競爭集合:Medicare 與 Medicaid 管理式醫療領域的 UnitedHealthcare、Elevance Health、CVS-Aetna 與 Cigna。

財務快照

總收入$129.66B(FY2025 收入)
營業利潤$2.70B(FY2025 營業利潤)
淨利潤$1.19B(FY2025 淨利潤)
稀釋 EPS$9.84(FY2025 GAAP 稀釋 EPS)
來源:Humana 2025 財年 Form 10-K(截至 2025 年 12 月 31 日)——收入、營業利潤與淨利潤經維基百科公司資料(10-K 數字)並由 10-K 報道佐證;GAAP 稀釋 EPS 9.84 美元經公司業績報道(調整後 EPS 為 17.14 美元)。板塊收入為含板塊間收入的板塊總額;保險 1,246 億美元加 CenterWell 225 億美元、減去板塊間抵銷 177 億美元,即與合併收入對賬。福利比率約 90.2%(保險板塊,2025 財年)。

主要風險

  • 星級評級:4 星或以上計劃的會員佔比下跌(按 10-K 報道由 94% 降至約 20%),為 2026 年及以後帶來數十億美元的獎金支付逆風。
  • 醫療成本趨勢:福利比率約 90.2%,若使用率升幅快於保費,幾乎沒有緩衝。
  • 政府定價:CMS 的 Medicare Advantage 費率、v28 風險模型與 Medicaid 資格重審,均由提供約 93% 收入的同一付款方決定。
  • 會員與利潤率:利潤率復甦計劃令 2025 年會員減少(醫療會員總數降至 1,500 萬);2026 年的重新增長不能重新引入無利可圖的會員。
  • 大型 Medicare 承辦商常見的監管與訴訟曝險,包括風險調整審計。

對標普500的重要性

Humana 是權重較小的醫療保健成分股:按權重排名 #232,權重 0.07%(以 Oct 30, 2026 為準),醫療保健板塊內排名 #30。作為指數中最純粹的大型 Medicare Advantage 保險商,其福利比率與星級評級是觀察美國政府健康計劃經濟學最清晰的實時指標。

來源與方法

財務、板塊、總部Humana 2025 財年 Form 10-K 數據,經維基百科公司資料與 10-K 報道(截至 2025 年 12 月 31 日);總部、執行長與員工經維基百科公司資料
指數權重與排名Slickcharts S&P 500 權重,Oct 30, 2026 收盤,Nov 2, 2026 抓取(派工基線,原文引用)
市值$49.77B(Oct 30, 2026)
LogoSPXSet logo 庫,整理自企業官方網站、文件或維基百科;由於是企業自身動態資訊,不對圖形做百分百保證。
股價圖SPXSet 圖表庫月線,整理自 Yahoo 公開資訊。

10年股價K線圖(月K)

HUM

來源:Yahoo Finance 月線(經拆股調整)· 數據截至 2026 年 9 月 30 日(最後已收月份)· SPXSet.com

財報

SPXSet Studio

SPXSet in-house research — market structure, options and volatility. Not investment advice.
SPXSet 站內獨立研究,聚焦 SPX 市場結構、期權與波動率;內容不構成投資建議。

SPXSet · Company Library · HUM
Data as of Oct 30, 2026 · Financials FY2025 (10-K) · Market data Oct 2026
Previous · Agilent Technologies, Inc. (A) — XLV Health Care · S&P 500 Profile |安捷倫公司介紹Next · Veeva Systems Inc. (VEEV) — XLV Health Care · S&P 500 Profile |Veeva公司介紹

Entered 2026-11-01 19:28 · updated 2026-11-14 23:32 · rev 5